270 related articles for article (PubMed ID: 18637487)
1. Progesterone receptor action: translating studies in breast cancer models to clinical insights.
Lange CA; Sartorius CA; Abdel-Hafiz H; Spillman MA; Horwitz KB; Jacobsen BM
Adv Exp Med Biol; 2008; 630():94-111. PubMed ID: 18637487
[TBL] [Abstract][Full Text] [Related]
2. Integration of progesterone receptor action with rapid signaling events in breast cancer models.
Lange CA
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):203-12. PubMed ID: 17964138
[TBL] [Abstract][Full Text] [Related]
3. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer.
Lange CA; Gioeli D; Hammes SR; Marker PC
Annu Rev Physiol; 2007; 69():171-99. PubMed ID: 17037979
[TBL] [Abstract][Full Text] [Related]
4. Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
Daniel AR; Qiu M; Faivre EJ; Ostrander JH; Skildum A; Lange CA
Steroids; 2007 Feb; 72(2):188-201. PubMed ID: 17173941
[TBL] [Abstract][Full Text] [Related]
5. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
[TBL] [Abstract][Full Text] [Related]
6. Integration of progesterone receptor mediated rapid signaling and nuclear actions in breast cancer cell models: role of mitogen-activated protein kinases and cell cycle regulators.
Faivre E; Skildum A; Pierson-Mullany L; Lange CA
Steroids; 2005; 70(5-7):418-26. PubMed ID: 15862825
[TBL] [Abstract][Full Text] [Related]
7. Progesterone receptor-B regulation of insulin-like growth factor-stimulated cell migration in breast cancer cells via insulin receptor substrate-2.
Ibrahim YH; Byron SA; Cui X; Lee AV; Yee D
Mol Cancer Res; 2008 Sep; 6(9):1491-8. PubMed ID: 18819936
[TBL] [Abstract][Full Text] [Related]
8. Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways.
Carnevale RP; Proietti CJ; Salatino M; Urtreger A; Peluffo G; Edwards DP; Boonyaratanakornkit V; Charreau EH; Bal de Kier Joffé E; Schillaci R; Elizalde PV
Mol Endocrinol; 2007 Jun; 21(6):1335-58. PubMed ID: 17440047
[TBL] [Abstract][Full Text] [Related]
9. Progesterone-independent effects of human progesterone receptors (PRs) in estrogen receptor-positive breast cancer: PR isoform-specific gene regulation and tumor biology.
Jacobsen BM; Schittone SA; Richer JK; Horwitz KB
Mol Endocrinol; 2005 Mar; 19(3):574-87. PubMed ID: 15563544
[TBL] [Abstract][Full Text] [Related]
10. [Aspects of progesterone receptor (PR) activity regulation - impact on breast cancer progression].
Piasecka D; Składanowski AC; Kordek R; Romańska HM; Sądej R
Postepy Biochem; 2015; 61(2):198-206. PubMed ID: 26689013
[TBL] [Abstract][Full Text] [Related]
11. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
12. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
13. Making sense of cross-talk between steroid hormone receptors and intracellular signaling pathways: who will have the last word?
Lange CA
Mol Endocrinol; 2004 Feb; 18(2):269-78. PubMed ID: 14563938
[TBL] [Abstract][Full Text] [Related]
14. The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle.
Boonyaratanakornkit V; McGowan E; Sherman L; Mancini MA; Cheskis BJ; Edwards DP
Mol Endocrinol; 2007 Feb; 21(2):359-75. PubMed ID: 17138644
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation-dependent antagonism of sumoylation derepresses progesterone receptor action in breast cancer cells.
Daniel AR; Faivre EJ; Lange CA
Mol Endocrinol; 2007 Dec; 21(12):2890-906. PubMed ID: 17717077
[TBL] [Abstract][Full Text] [Related]
17. Breast Cancer Suppression by Progesterone Receptors Is Mediated by Their Modulation of Estrogen Receptors and RNA Polymerase III.
Finlay-Schultz J; Gillen AE; Brechbuhl HM; Ivie JJ; Matthews SB; Jacobsen BM; Bentley DL; Kabos P; Sartorius CA
Cancer Res; 2017 Sep; 77(18):4934-4946. PubMed ID: 28729413
[TBL] [Abstract][Full Text] [Related]
18. Hypothesis: Progesterone primes breast cancer cells for cross-talk with proliferative or antiproliferative signals.
Lange CA; Richer JK; Horwitz KB
Mol Endocrinol; 1999 Jun; 13(6):829-36. PubMed ID: 10379882
[TBL] [Abstract][Full Text] [Related]
19. Progesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexes.
Daniel AR; Gaviglio AL; Knutson TP; Ostrander JH; D'Assoro AB; Ravindranathan P; Peng Y; Raj GV; Yee D; Lange CA
Oncogene; 2015 Jan; 34(4):506-15. PubMed ID: 24469035
[TBL] [Abstract][Full Text] [Related]
20. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
Liang Y; Wu J; Stancel GM; Hyder SM
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]